A phase 3 randomized trial of sulopenem vs. ertapenem in patients with complicated intra-abdominal infections.

MLA

Dunne, Michael W., et al. “A Phase 3 Randomized Trial of Sulopenem vs. Ertapenem in Patients with Complicated Intra-Abdominal Infections.” Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, Nov. 2024. EBSCOhost, https://doi.org/10.1016/j.cmi.2024.10.025.

APA

Dunne, M. W., Aronin, S. I., Das, A. F., Akinapelli, K., Breen, J. D., Zelasky, M. T., & Puttagunta, S. (2024). A phase 3 randomized trial of sulopenem vs. ertapenem in patients with complicated intra-abdominal infections. Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. https://doi.org/10.1016/j.cmi.2024.10.025

Chicago

Dunne, Michael W, Steven I Aronin, Anita F Das, Karthik Akinapelli, Jeanne D Breen, Michael T Zelasky, and Sailaja Puttagunta. 2024. “A Phase 3 Randomized Trial of Sulopenem vs. Ertapenem in Patients with Complicated Intra-Abdominal Infections.” Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, November. doi:10.1016/j.cmi.2024.10.025.